Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
Portfolio Pulse from Avi Kapoor
Wall Street's most accurate analysts have provided updates on three high-dividend yielding health care stocks: Amgen Inc. (AMGN), Medtronic plc (MDT), and AbbVie Inc. (ABBV). These updates include changes in price targets and ratings, reflecting the analysts' views on the stocks' future performance. Additionally, recent news for each company includes Amgen's new manufacturing site, Medtronic's ITC action against Axonics, and AbbVie's partnership with OSE Immunotherapeutics.
March 01, 2024 | 12:52 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AbbVie Inc. received a price target increase from Truist Securities and a downgrade from HSBC. The partnership with OSE Immunotherapeutics for a novel monoclonal antibody could be a significant growth driver.
Despite mixed analyst ratings, the strategic partnership for developing a novel monoclonal antibody indicates potential for significant advancements and growth in chronic inflammation treatment.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Amgen Inc. received mixed analyst ratings with a slight price target cut by Morgan Stanley and an increase by RBC Capital. The opening of a new manufacturing site could signal strong future prospects.
The mixed analyst ratings indicate a cautious optimism, while the new manufacturing site suggests operational expansion and potential for growth, likely positively impacting the stock.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Medtronic plc saw its price target increased by both Oppenheimer and Truist Securities. The company's recent ITC action against Axonics could strengthen its competitive position.
The increased price targets reflect analyst confidence in Medtronic's performance. The ITC action suggests proactive measures to protect its innovations, potentially enhancing its market position.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90